Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,556.37
(
-0.37%
)
US TECH 100
23,550.80
(
0.13%
)
Dow Jones
46,124.06
(
-0.18%
)
Brent Oil
96.50
(
-0.30%
)
Bitcoin
70,518.00
(
-0.54%
)
News Focus
News Focus
Post# of 257275
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rajaram46 post# 180687

Thursday, 07/24/2014 3:33:55 PM

Thursday, July 24, 2014 3:33:55 PM

Post# of 257275

What do you think of GILD's valuation now? I know you wanted to buy in the low 60's. Are you still concerned about the HIV franchise?

Yes, my opinion in #msg-100313128—that investors are underestimating the risk to GILD’s HIV franchise if TAF fails to meet expectations—still stands until the initial TAF phase-3 data are reported in 4Q14.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today